SCNI(SCNI)
SCNI
No analyst ratings available
No analyst price targets available for SCNI
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $544,821 | $575,859 | $608,666 | $643,341 | $679,992 | $718,730 | $759,676 | $802,954 |
| Low | $544,821 | $575,859 | $608,666 | $643,341 | $679,992 | $718,730 | $759,676 | $802,954 |
| High | $544,821 | $575,859 | $608,666 | $643,341 | $679,992 | $718,730 | $759,676 | $802,954 |
| EBITDA Avg | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| Low | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| High | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| EBIT Avg | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| Low | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| High | $108,964 | $115,171 | $121,733 | $128,668 | $135,998 | $143,745 | $151,935 | $160,590 |
| Net Income Avg | $-8,054 | $-8,054 | $-8,054 | $-947 | $-947 | $-947 | $-20,848 | $-4,311 |
| Low | $-8,054 | $-8,054 | $-8,054 | $-947 | $-947 | $-947 | $-20,848 | $-4,311 |
| High | $-8,054 | $-8,054 | $-8,054 | $-947 | $-947 | $-947 | $-20,848 | $-4,311 |
| EPS Avg | $-8.50 | $-8.50 | $-8.50 | $-1.00 | $-1.00 | $-1.00 | $-22.00 | $-4.55 |
| Low | $-8.50 | $-8.50 | $-8.50 | $-1.00 | $-1.00 | $-1.00 | $-22.00 | $-4.55 |
| High | $-8.50 | $-8.50 | $-8.50 | $-1.00 | $-1.00 | $-1.00 | $-22.00 | $-4.55 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |